• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Novo vs. KBP: How a $1.3B deal turned into an international legal fight
Genentech
Marketing

Genentech’s 1st DTC program centers on discounted Xofluza

Genentech is joining the wave of drugmakers setting up DTC sales of popular products at steep discounts for cash-paying patients.
Andrea Park Oct 16, 2025 1:42pm
SIN169RatioImage 1jpg
Sponsored

Astellas’ Vision: Transforming Precision Cancer Care

Oct 13, 2025 8:00am
merck

In ovarian cancer, Keytruda follows PFS win with survival showing

Oct 16, 2025 10:23am
Destination Surescripts Accelerating Patient Access for Better Care
Sponsored

Destination Surescripts: Accelerating Patient Access

Oct 13, 2025 8:00am
NVS

Novartis advances IgAN efforts with another phase 3 win

Oct 16, 2025 9:30am
Johnson  Johnson

J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win

Oct 16, 2025 8:10am
More News

Veradermics grows hair loss med hopes on $150M funding wave

Oct 16, 2025 7:30am
Fierce Biotech

Diabetes drug soothes brain inflammation in female mice with MS

Oct 15, 2025 6:16pm

Regulatory tracker: GSK's Shingrix gains China expansion

Oct 15, 2025 1:30pm

AZ to spend $445M to boost production of Lokelma at Texas plant

Oct 15, 2025 11:43am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings